Diet and Oxaliplatin

 

If you are undergoing treatment for cancer, your health care team will advise you about general dietary recommendations that are helpful. This may include instructions such as avoiding citrus food;spicy, acidic, or very hot food; salty items; alcohol;and tobacco.Always follow the recommendations provided by your doctor and nurse. In addition to this, you may need totake some additional dietary precautions if you are taking Oxaliplatin as part of your cancer treatment.

Cold Food and Oxaliplatin

  • If you are receiving Oxaliplatin as part of your cancer treatment, you will need to avoid very coldand frozen food on the day of your treatment (infusion) and for up to 5 days after treatment.
  • If you enjoy cold and frozen food and beverages, be sure to treat yourself to one last cold fruit juice, ice tea,ice cream, or otheritem you enjoy before your treatment. Then it won't be as difficult to avoid these things for the next 5 days.
  • Also be cautious with handling cold items, such as when taking frozen food out of the freezer or handling a soda can out of the refrigerator. This can cause discomfort where the cold item touches your skin.

Remember, you only need to take these precautions for approximately 5 days after you receive Oxaliplatin. After that time, your sensitivity to cold should return to normal.

Latest Cancer News
ACS Guidelines for Breast Screening with MRI May Be Excluding Some High-risk Women

January 6, 2009 — The American Cancer Society (ACS) has developed a set of guidelines to recommend which high-risk women need to undergo screening with breast magnetic resonance imaging (MRI); however, these guidelines may unwittingly exclude some women who are at a high risk of carrying the BRCA mutation yet still don’t meet the limitations set by the ACS. The results of this study were published in the journal Cancer.

Colonoscopy Fails to Identify Many Colorectal Cancers

January 6, 2009 — Colonoscopy, a standard screening method for colorectal cancer, misses the majority of cancers on the right side of the colon and about one-third of cancers on the left side of the colon, according to the results of a study published in the Annals of Internal Medicine. The researchers estimated that the screening method may reduce colorectal cancer mortality by 60-70%, rather than 90% as previously estimated.

High-dose Faslodex® Improves Time to Progression Compared with Arimidex® as Initial Therapy in Advanced Breast Cancer

January 6, 2009 — Researchers affiliated with an international trial have reported that high-dose Faslodex® (fulvestrant) significantly improves time to cancer progression compared with Arimidex® (anastrozole) as initial therapy for hormone-positive, advanced breast cancer. These results were recently presented at the 2008 annual San Antonio Breast Cancer Symposium December 10-14, 2008.

Select news items provided by Reuters Health